Empowered Relief Study
Empowered Relief for Osteoarthritis (OA)
"Empowered Relief" (ER) Intervention was developed by Beth Darnall, PhD at what is now the Stanford Pain Relief Innovations Lab. Our design is a randomized 3-arm study with test treatment, active control, and placebo arms. Our goals are to provide scientific evidence to demonstrate the efficacy of ER, and also provide a comparison of said efficacy against the standard of care - group pain-CBT. Treatment allocation is randomized to minimize confounder effects. Statisticians performing analyses will be blinded.
The primary objective of this study is to evaluate the efficacy of Empowered Relief (a novel, single-session (2-hour), evidence-based online pain management class) on reducing pain burden and improving quality of life in patients with advanced osteoarthritis. Empowered Relief is designed to compress key cognitive behavioral therapy (CBT) skills, mindfulness principles, and pain neuroscience education into a brief, scalable format.
Specifically, the study aims to: Evaluate Clinical Outcomes: Determine whether the intervention reduces pain burden and enhances mobility.
Assess Psychological & Behavioral Impact: Examine whether the intervention improves patient-reported understanding of pain, fosters self-efficacy, and increases perceived control, thereby promoting active engagement in their own pain management.
Subject Population: The subject population consists of adult patients diagnosed with advanced osteoarthritis (KL Grade 3-4) who have been deferred from total hip or total knee arthroplasty (THA/TKA). Deferment criteria for this population include existing medical, surgical, behavioral, or personal barriers that currently preclude them from undergoing joint replacement surgery. This population is particularly vulnerable to prolonged suffering, decreased mobility, and compounding psychosocial distress while managing severe somatic pain without immediate surgical options.
Main Research Procedures: The study will utilize a prospective, longitudinal design to measure the impact of the Empowered Relief intervention on the target population.
The main procedures include: Intervention Delivery: Eligible participants will complete the live Empowered Relief online class (via Zoom) with a certified instructor (Dr. Caryn Lindsey), a 2-hour intervention equipping them with accessible, evidence-based behavioral pain management skills.
Data Collection Schedule: Participants will be assessed at three distinct time points: Baseline (pre-intervention), 4-weeks post-treatment, and 8-weeks post-treatment.
調査の概要
研究の種類
入学 (推定)
段階
- 適用できない
連絡先と場所
研究連絡先
- 名前:Jordan Bernstein
- 電話番号:5514973176
- メール:jordan.bernstein@cshs.org
研究場所
-
-
California
-
Los Angeles、California、アメリカ、90048
- Cedars Sinai
-
コンタクト:
- Jordan Bernstein
- 電話番号:551-497-3176
- メール:jordan.bernstein@cshs.org
-
-
参加基準
適格基準
就学可能な年齢
- 大人
- 高齢者
健康ボランティアの受け入れ
説明
Inclusion Criteria:
- Adults age 18 or older who are eligible and interested in enrolling
Exclusion Criteria:
- Any records flagged "break the glass" or "research opt out"
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:処理
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:なし(オープンラベル)
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的:Test Treatment
|
2-hour pain management course
|
|
アクティブコンパレータ:Educational Materials
Patients will be provided with a handout from the U.S. Pain Foundation titled "Self Management Strategies"
|
"Self Management Strategies" is an educational handout from the US Pain Foundation
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Pain Catastrophizing Scale (PCS)
時間枠:Once at baseline, then at weeks 2, 4, 8, and 12.
|
Once at baseline, then at weeks 2, 4, 8, and 12.
|
|
|
NIH Patient-Reported Outcomes Measurement Information System (PROMIS) Measures
時間枠:Once at baseline, then at weeks 2, 4, 8, and 12
|
Questions related to pain, physical function, and depression.
|
Once at baseline, then at weeks 2, 4, 8, and 12
|
|
Pain Self-Efficacy Questionnaire
時間枠:Once at baseline, then at weeks 2, 4, 8, and 12
|
Once at baseline, then at weeks 2, 4, 8, and 12
|
協力者と研究者
出版物と役立つリンク
一般刊行物
- 3. Wertli, M.M., et al., The Influence of Catastrophizing on Treatment Outcome in Patients With Non-Specific Low Back Pain: A Systematic Review. Spine (Phila Pa 1976), 2013.
- 2. CDC, Prevalence and Most Common Causes of Disability Among Adults --- United States, 2005. MMWR, 2009. 58(16): p. 421-416.
- 1. Freburger, J.K., et al., The rising prevalence of chronic low back pain. Arch Intern Med, 2009. 169(3): p. 251-8.
研究記録日
主要日程の研究
研究開始 (推定)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。